company background image
TRHC

Tabula Rasa HealthCare NasdaqGM:TRHC Stock Report

Last Price

US$3.24

Market Cap

US$77.5m

7D

-16.9%

1Y

-92.0%

Updated

16 May, 2022

Data

Company Financials +
TRHC fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health1/6
Dividends0/6

TRHC Stock Overview

Tabula Rasa HealthCare, Inc. operates as a healthcare technology company in the United States.

Tabula Rasa HealthCare Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Tabula Rasa HealthCare
Historical stock prices
Current Share PriceUS$3.24
52 Week HighUS$53.38
52 Week LowUS$2.77
Beta1.54
1 Month Change-27.19%
3 Month Change-60.82%
1 Year Change-92.01%
3 Year Change-92.96%
5 Year Change-73.33%
Change since IPO-78.23%

Recent News & Updates

May 11
Does Tabula Rasa HealthCare (NASDAQ:TRHC) Have A Healthy Balance Sheet?

Does Tabula Rasa HealthCare (NASDAQ:TRHC) Have A Healthy Balance Sheet?

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

Shareholder Returns

TRHCUS Healthcare ServicesUS Market
7D-16.9%0.8%0.7%
1Y-92.0%-36.4%-10.8%

Return vs Industry: TRHC underperformed the US Healthcare Services industry which returned -35.3% over the past year.

Return vs Market: TRHC underperformed the US Market which returned -10.4% over the past year.

Price Volatility

Is TRHC's price volatile compared to industry and market?
TRHC volatility
TRHC Average Weekly Movement18.9%
Healthcare Services Industry Average Movement12.1%
Market Average Movement7.8%
10% most volatile stocks in US Market16.8%
10% least volatile stocks in US Market2.9%

Stable Share Price: TRHC is more volatile than 90% of US stocks over the past 3 months, typically moving +/- 19% a week.

Volatility Over Time: TRHC's weekly volatility (19%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
20091,602Calvin Knowltonhttps://www.tabularasahealthcare.com

Tabula Rasa HealthCare, Inc. operates as a healthcare technology company in the United States. The company operates in two segments, CareVention HealthCare and MedWise HealthCare. It offers EireneRx, a cloud-based medication decision-support and e-prescribing platform to access patient medication-related information; and MedWise medication therapy management software, a cloud-based platform designed to aid in the identification and resolution of medication and health-related problems.

Tabula Rasa HealthCare Fundamentals Summary

How do Tabula Rasa HealthCare's earnings and revenue compare to its market cap?
TRHC fundamental statistics
Market CapUS$77.47m
Earnings (TTM)-US$86.07m
Revenue (TTM)US$339.59m

0.2x

P/S Ratio

-0.9x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
TRHC income statement (TTM)
RevenueUS$339.59m
Cost of RevenueUS$242.10m
Gross ProfitUS$97.49m
Other ExpensesUS$183.57m
Earnings-US$86.07m

Last Reported Earnings

Mar 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-3.60
Gross Margin28.71%
Net Profit Margin-25.35%
Debt/Equity Ratio1,040.1%

How did TRHC perform over the long term?

See historical performance and comparison

Valuation

Is Tabula Rasa HealthCare undervalued compared to its fair value and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • PE vs Industry

  • PE vs Market

  • PEG Ratio

  • PB vs Industry


>50%

Undervalued compared to fair value

Share Price vs. Fair Value

Below Fair Value: TRHC ($3.24) is trading below our estimate of fair value ($17.91)

Significantly Below Fair Value: TRHC is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: TRHC is unprofitable, so we can't compare its PE Ratio to the US Healthcare Services industry average.

PE vs Market: TRHC is unprofitable, so we can't compare its PE Ratio to the US market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate TRHC's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: TRHC's PB Ratio (2.1x) is in line with the US Healthcare Services industry average.


Future Growth

How is Tabula Rasa HealthCare forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?

Future Growth Score

0/6

Future Growth Score 0/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


23.7%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: TRHC is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: TRHC is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: TRHC is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: TRHC's revenue is expected to decline over the next 3 years (-5.3% per year).

High Growth Revenue: TRHC's revenue is forecast to decline over the next 3 years (-5.3% per year).


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if TRHC's Return on Equity is forecast to be high in 3 years time


Past Performance

How has Tabula Rasa HealthCare performed over the past 5 years?

Past Performance Score

0/6

Past Performance Score 0/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


-44.0%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: TRHC is currently unprofitable.

Growing Profit Margin: TRHC is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: TRHC is unprofitable, and losses have increased over the past 5 years at a rate of 44% per year.

Accelerating Growth: Unable to compare TRHC's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: TRHC is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (6.6%).


Return on Equity

High ROE: TRHC has a negative Return on Equity (-237.56%), as it is currently unprofitable.


Financial Health

How is Tabula Rasa HealthCare's financial position?

Financial Health Score

1/6

Financial Health Score 1/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Stable Cash Runway

  • Forecast Cash Runway

Financial Position Analysis

Short Term Liabilities: TRHC's short term assets ($289.1M) exceed its short term liabilities ($76.2M).

Long Term Liabilities: TRHC's short term assets ($289.1M) do not cover its long term liabilities ($394.4M).


Debt to Equity History and Analysis

Debt Level: TRHC's net debt to equity ratio (1000.2%) is considered high.

Reducing Debt: TRHC's debt to equity ratio has increased from 0% to 1040.1% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: TRHC has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if TRHC has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Dividend

What is Tabula Rasa HealthCare current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Future Dividend Coverage

Dividend Yield vs Market

Notable Dividend: Unable to evaluate TRHC's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate TRHC's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if TRHC's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if TRHC's dividend payments have been increasing.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as TRHC has not reported any payouts.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

6.7yrs

Average management tenure


CEO

Calvin Knowlton (71 yo)

7.92yrs

Tenure

US$5,971,425

Compensation

Dr. Calvin H. Knowlton, BSc Pharm, MDiv, Ph.D. ScD (Hon), is a Co-Founder of Tabula Rasa Healthcare, Inc. and has been its Chairman and Chief Executive Officer since June 2014. Dr. Knowlton founded Tabula...


CEO Compensation Analysis

Compensation vs Market: Calvin's total compensation ($USD5.97M) is above average for companies of similar size in the US market ($USD770.21K).

Compensation vs Earnings: Calvin's compensation has increased whilst the company is unprofitable.


Leadership Team

Experienced Management: TRHC's management team is seasoned and experienced (6.7 years average tenure).


Board Members

Experienced Board: TRHC's board of directors are considered experienced (4.8 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: TRHC insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Tabula Rasa HealthCare, Inc.'s employee growth, exchange listings and data sources


Key Information

  • Name: Tabula Rasa HealthCare, Inc.
  • Ticker: TRHC
  • Exchange: NasdaqGM
  • Founded: 2009
  • Industry: Health Care Technology
  • Sector: Healthcare
  • Implied Market Cap: US$77.470m
  • Shares outstanding: 23.91m
  • Website: https://www.tabularasahealthcare.com

Number of Employees


Location

  • Tabula Rasa HealthCare, Inc.
  • 228 Strawbridge Drive
  • Suite 100
  • Moorestown
  • New Jersey
  • 8057
  • United States

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/05/16 00:00
End of Day Share Price2022/05/16 00:00
Earnings2022/03/31
Annual Earnings2021/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.